cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.7908257.v1
title: gVCF_HG01894

description: 1000 Genomes gVCF mapped to hs37d5 for HG01894. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908158
title: gVCF_HG01893

description: 1000 Genomes gVCF mapped to hs37d5 for HG01893. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908173
title: gVCF_NA19005

description: 1000 Genomes gVCF mapped to hs37d5 for NA19005. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908146
title: gVCF_HG03583

description: 1000 Genomes gVCF mapped to hs37d5 for HG03583. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908158.v1
title: gVCF_HG01893

description: 1000 Genomes gVCF mapped to hs37d5 for HG01893. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908101
title: gVCF_HG01892

description: 1000 Genomes gVCF mapped to hs37d5 for HG01892. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908146.v1
title: gVCF_HG03583

description: 1000 Genomes gVCF mapped to hs37d5 for HG03583. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908092
title: gVCF_NA19004

description: 1000 Genomes gVCF mapped to hs37d5 for NA19004. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908095
title: gVCF_HG03578

description: 1000 Genomes gVCF mapped to hs37d5 for HG03578. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908095.v1
title: gVCF_HG03578

description: 1000 Genomes gVCF mapped to hs37d5 for HG03578. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908083
title: preinHPO-differential lncRNA GO KEGG

description: preinHPO-differential-lncRNA-GO-KEGG
DOI: 10.6084/m9.figshare.7908086
title: Supplementary data from Parental care and the evolution of terrestriality in frogs

description: Frogs and toads (Anura) exhibit some of the most diverse parental strategies in vertebrates. Identifying the evolutionary origins of parenting is fundamental to understanding the relationships between sexual selection, social evolution and parental care systems of contemporary Anura. Moreover, parenting has been hypothesized to allow the invasion of terrestrial habitats by the ancestors of terrestrial vertebrates. Using comprehensive phylogenetic analyses of frogs and toads based on data from over 1000 species that represent 46 out of 55 Anura families, we test whether parental care is associated with terrestrial reproduction and several life-history traits. Here, we show that both the duration of care and offspring protection by males and females have coevolved with terrestrial reproduction. Sexual size dimorphism is also related to care, because the large male size relative to female size is associated with increased paternal care. Furthermore, increased egg size and reduced clutch volume are associated with increased care in bivariate but not in multivariate analyses, suggesting that the relationships between care, egg size and clutch volume are mediated by terrestrial reproduction. Taken together, our results suggest that parenting by males and females has coevolved, and complex parenting traits have evolved several times independently in Anura in response to breeding in terrestrial environments.
DOI: 10.6084/m9.figshare.7908092.v1
title: gVCF_NA19004

description: 1000 Genomes gVCF mapped to hs37d5 for NA19004. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908071
title: gVCF_HG01890

description: 1000 Genomes gVCF mapped to hs37d5 for HG01890. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908083.v1
title: preinHPO-differential lncRNA GO KEGG

description: preinHPO-differential-lncRNA-GO-KEGG
DOI: 10.6084/m9.figshare.7908086.v1
title: Supplementary data from Parental care and the evolution of terrestriality in frogs

description: Frogs and toads (Anura) exhibit some of the most diverse parental strategies in vertebrates. Identifying the evolutionary origins of parenting is fundamental to understanding the relationships between sexual selection, social evolution and parental care systems of contemporary Anura. Moreover, parenting has been hypothesized to allow the invasion of terrestrial habitats by the ancestors of terrestrial vertebrates. Using comprehensive phylogenetic analyses of frogs and toads based on data from over 1000 species that represent 46 out of 55 Anura families, we test whether parental care is associated with terrestrial reproduction and several life-history traits. Here, we show that both the duration of care and offspring protection by males and females have coevolved with terrestrial reproduction. Sexual size dimorphism is also related to care, because the large male size relative to female size is associated with increased paternal care. Furthermore, increased egg size and reduced clutch volume are associated with increased care in bivariate but not in multivariate analyses, suggesting that the relationships between care, egg size and clutch volume are mediated by terrestrial reproduction. Taken together, our results suggest that parenting by males and females has coevolved, and complex parenting traits have evolved several times independently in Anura in response to breeding in terrestrial environments.
DOI: 10.6084/m9.figshare.7908065
title: gVCF_HG03577

description: 1000 Genomes gVCF mapped to hs37d5 for HG03577. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908071.v1
title: gVCF_HG01890

description: 1000 Genomes gVCF mapped to hs37d5 for HG01890. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908047
title: gVCF_HG03575

description: 1000 Genomes gVCF mapped to hs37d5 for HG03575. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908059
title: CiteSeq data (Seurat object)

description: Seurat object generated, following the "Multimodal Vignette" workflow (https://satijalab.org/seurat/multimodal_vignette.html). In addition to the workflow, the UMAP embedding has been calculated. Data from this objects are used to produce Sleepwalk examples throughout the paper.(data are taken from Stoeckius et al., <i>Simultaneous epitope and transcriptome measurement in single cells</i>, Nature Methods, 14:865, 2017)<br>
DOI: 10.6084/m9.figshare.7908065.v1
title: gVCF_HG03577

description: 1000 Genomes gVCF mapped to hs37d5 for HG03577. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908056
title: gVCF_NA19003

description: 1000 Genomes gVCF mapped to hs37d5 for NA19003. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908038
title: gVCF_HG01889

description: 1000 Genomes gVCF mapped to hs37d5 for HG01889. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908047.v1
title: gVCF_HG03575

description: 1000 Genomes gVCF mapped to hs37d5 for HG03575. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908056.v1
title: gVCF_NA19003

description: 1000 Genomes gVCF mapped to hs37d5 for NA19003. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908059.v1
title: CiteSeq data (Seurat object)

description: Seurat object generated, following the "Multimodal Vignette" workflow (https://satijalab.org/seurat/multimodal_vignette.html). In addition to the workflow, the UMAP embedding has been calculated. Data from this objects are used to produce Sleepwalk examples throughout the paper.(data are taken from Stoeckius et al., <i>Simultaneous epitope and transcriptome measurement in single cells</i>, Nature Methods, 14:865, 2017)<br>
DOI: 10.6084/m9.figshare.7908023
title: GO and KEGG analysis of cis- and trans-acting target genes of differential lncRNA in hypothalamus, pituitary and follicle

description: GO and KEGG analysis of cis- and trans-acting target genes of differential lncRNA in hypothalamus, pituitary and follicle
DOI: 10.6084/m9.figshare.7908026
title: gVCF_NA19002

description: 1000 Genomes gVCF mapped to hs37d5 for NA19002. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908029
title: gVCF_HG03572

description: 1000 Genomes gVCF mapped to hs37d5 for HG03572. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908020
title: gVCF_HG01886

description: 1000 Genomes gVCF mapped to hs37d5 for HG01886. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908023.v1
title: GO and KEGG analysis of cis- and trans-acting target genes of differential lncRNA in hypothalamus, pituitary and follicle

description: GO and KEGG analysis of cis- and trans-acting target genes of differential lncRNA in hypothalamus, pituitary and follicle
DOI: 10.6084/m9.figshare.7908029.v1
title: gVCF_HG03572

description: 1000 Genomes gVCF mapped to hs37d5 for HG03572. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908038.v1
title: gVCF_HG01889

description: 1000 Genomes gVCF mapped to hs37d5 for HG01889. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908026.v1
title: gVCF_NA19002

description: 1000 Genomes gVCF mapped to hs37d5 for NA19002. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908008
title: gVCF_NA19001

description: 1000 Genomes gVCF mapped to hs37d5 for NA19001. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908011
title: gVCF_HG03571

description: 1000 Genomes gVCF mapped to hs37d5 for HG03571. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908002
title: gVCF_HG01885

description: 1000 Genomes gVCF mapped to hs37d5 for HG01885. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908011.v1
title: gVCF_HG03571

description: 1000 Genomes gVCF mapped to hs37d5 for HG03571. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907999
title: Supplementary Material for: Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus

description: <b><i>Background:</i></b> Hypertension and renal injury are common complications of type 2 diabetes mellitus (T2DM). Hyperglycemia stimulates renal proximal tubular angiotensinogen (AGT) expression via elevated oxidative stress contributing to the development of high blood pressure and diabetic nephropathy. The sodium glucose cotransporter 2 (SGLT2) in proximal tubules is responsible for the majority of glucose reabsorption by renal tubules. We tested the hypothesis that SGLT2 inhibition with canagliflozin (CANA) prevents intrarenal AGT augmentation and ameliorates kidney injury and hypertension in T2DM. <b><i>Methods:</i></b> We induced T2DM in New Zealand obese mice with a high fat diet (DM, 30% fat) with control mice receiving regular fat diet (ND, 4% fat). When DM mice exhibited &gt; 350 mg/dL blood glucose levels, both DM- and ND-fed mice were treated with 10 mg/kg/day CANA or vehicle by oral gavage for 6 weeks. We evaluated intrarenal AGT, blood pressure, and the development of kidney injury. <b><i>Results:</i></b> Systolic blood pressure in DM mice (133.9 ± 2.0 mm Hg) was normalized by CANA (113.9 ± 4.0 mm Hg). CANA treatment ameliorated hyperglycemia-associated augmentation of renal AGT mRNA (148 ± 21 copies/ng RNA in DM, and 90 ± 16 copies/ng RNA in DM + CANA) and protein levels as well as elevation of urinary 8-isoprostane levels. Tubular fibrosis in DM mice (3.4 ± 0.9-fold, fibrotic score, ratio to ND) was suppressed by CANA (0.9 ± 0.3-fold). Furthermore, CANA attenuated DM associated increased macrophage infiltration and cell proliferation in kidneys of DM mice. <b><i>Conclusions:</i></b> CANA prevents intrarenal AGT upregulation and oxidative stress and which may mitigate high blood pressure, renal tubular fibrosis, and renal inflammation in T2DM.
DOI: 10.6084/m9.figshare.7908002.v1
title: gVCF_HG01885

description: 1000 Genomes gVCF mapped to hs37d5 for HG01885. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7908008.v1
title: gVCF_NA19001

description: 1000 Genomes gVCF mapped to hs37d5 for NA19001. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907942
title: gVCF_HG01882

description: 1000 Genomes gVCF mapped to hs37d5 for HG01882. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907957
title: gVCF_HG03567

description: 1000 Genomes gVCF mapped to hs37d5 for HG03567. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907963
title: GO and KEGG analysis of differential coding genes in hypothalamus, pituitary and folllicles

description: differential coding genes in hypothalamus, pituitary and folllicles
DOI: 10.6084/m9.figshare.7907978
title: gene expression in preinH, preinP and preinO

description: gene expression in preinH, preinP and preinO
DOI: 10.6084/m9.figshare.7907978.v1
title: gene expression in preinH, preinP and preinO

description: gene expression in preinH, preinP and preinO
DOI: 10.6084/m9.figshare.7907939
title: gVCF_HG03565

description: 1000 Genomes gVCF mapped to hs37d5 for HG03565. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907954
title: gVCF_HG01883

description: 1000 Genomes gVCF mapped to hs37d5 for HG01883. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907942.v1
title: gVCF_HG01882

description: 1000 Genomes gVCF mapped to hs37d5 for HG01882. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907954.v1
title: gVCF_HG01883

description: 1000 Genomes gVCF mapped to hs37d5 for HG01883. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907939.v1
title: gVCF_HG03565

description: 1000 Genomes gVCF mapped to hs37d5 for HG03565. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907870
title: gVCF_HG01880

description: 1000 Genomes gVCF mapped to hs37d5 for HG01880. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907870.v1
title: gVCF_HG01880

description: 1000 Genomes gVCF mapped to hs37d5 for HG01880. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907768
title: gVCF_NA19000

description: 1000 Genomes gVCF mapped to hs37d5 for NA19000. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907768.v1
title: gVCF_NA19000

description: 1000 Genomes gVCF mapped to hs37d5 for NA19000. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907711
title: gVCF_HG01879

description: 1000 Genomes gVCF mapped to hs37d5 for HG01879. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907720
title: gVCF_HG03563

description: 1000 Genomes gVCF mapped to hs37d5 for HG03563. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907711.v1
title: gVCF_HG01879

description: 1000 Genomes gVCF mapped to hs37d5 for HG01879. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907720.v1
title: gVCF_HG03563

description: 1000 Genomes gVCF mapped to hs37d5 for HG03563. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907681
title: gVCF_NA18999

description: 1000 Genomes gVCF mapped to hs37d5 for NA18999. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907693
title: Data from 'Critical predictors of functional, phylogenetic, and taxonomic diversity are geographically structured in lichen epiphytic communities'

description: There are two spreadsheets: 'Data' and 'Metadata'. 'Data' contains the raw data used in the structural equation models (SEMs). 'Metadata' includes the description of all the variables and units. All the methodological details can be found in the manuscript (Journal of Ecology).
DOI: 10.6084/m9.figshare.7907672
title: DMR.txt

description: pre-in-follicle
DOI: 10.6084/m9.figshare.7907666
title: gVCF_HG01878

description: 1000 Genomes gVCF mapped to hs37d5 for HG01878. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907669
title: Supplementary Material for: Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting

description: <b><i>Background:</i></b> Upper airway stimulation (UAS) is a treatment approach for patients with moderate-to-severe obstructive sleep apnea who cannot adhere to continuous positive airway pressure therapy. <b><i>Objective:</i></b> The objective was to evaluate added patient benefit and cost-effectiveness of UAS in the German health care system. <b><i>Methods:</i></b> We used a decision-analytic Markov model to project major adverse cardiovascular or cerebrovascular events (myocardial infarction [MI] or stroke), motor vehicle collision (MVC), mortality, quality-adjusted life years (QALYs), and costs. The assumed reduction in the apnea-hypopnea index with UAS compared to no treatment is based on German real-world data. Other input data were derived from the literature, public statistics, and multivariate regression. Cost-effectiveness was evaluated in Euros per QALY gained, both discounted at 3%. <b><i>Results:</i></b> UAS was projected to reduce event risks (10-year relative risk for stroke, MI, cardiovascular death, and MVC: 0.76, 0.64, 0.65, and 0.34, respectively), and to increase survival by 1.27 years. While the UAS strategy incurred an additional 1.02 QALYs within the patient lifetime, there were also additional costs of EUR 45,196, resulting in an incremental cost-effectiveness ratio of EUR 44,446 per QALY gained. ­<b><i>Conclusions:</i></b> In the present model-based analysis, UAS therapy provides meaningful benefit to patient-relevant endpoints and is a cost-effective therapy in the German setting.
DOI: 10.6084/m9.figshare.7907678
title: gVCF_HG03559

description: 1000 Genomes gVCF mapped to hs37d5 for HG03559. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907681.v1
title: gVCF_NA18999

description: 1000 Genomes gVCF mapped to hs37d5 for NA18999. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907660
title: gVCF_NA18998

description: 1000 Genomes gVCF mapped to hs37d5 for NA18998. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907666.v1
title: gVCF_HG01878

description: 1000 Genomes gVCF mapped to hs37d5 for HG01878. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907669.v1
title: Supplementary Material for: Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting

description: <b><i>Background:</i></b> Upper airway stimulation (UAS) is a treatment approach for patients with moderate-to-severe obstructive sleep apnea who cannot adhere to continuous positive airway pressure therapy. <b><i>Objective:</i></b> The objective was to evaluate added patient benefit and cost-effectiveness of UAS in the German health care system. <b><i>Methods:</i></b> We used a decision-analytic Markov model to project major adverse cardiovascular or cerebrovascular events (myocardial infarction [MI] or stroke), motor vehicle collision (MVC), mortality, quality-adjusted life years (QALYs), and costs. The assumed reduction in the apnea-hypopnea index with UAS compared to no treatment is based on German real-world data. Other input data were derived from the literature, public statistics, and multivariate regression. Cost-effectiveness was evaluated in Euros per QALY gained, both discounted at 3%. <b><i>Results:</i></b> UAS was projected to reduce event risks (10-year relative risk for stroke, MI, cardiovascular death, and MVC: 0.76, 0.64, 0.65, and 0.34, respectively), and to increase survival by 1.27 years. While the UAS strategy incurred an additional 1.02 QALYs within the patient lifetime, there were also additional costs of EUR 45,196, resulting in an incremental cost-effectiveness ratio of EUR 44,446 per QALY gained. ­<b><i>Conclusions:</i></b> In the present model-based analysis, UAS therapy provides meaningful benefit to patient-relevant endpoints and is a cost-effective therapy in the German setting.
DOI: 10.6084/m9.figshare.7907678.v1
title: gVCF_HG03559

description: 1000 Genomes gVCF mapped to hs37d5 for HG03559. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907651
title: gVCF_HG03558

description: 1000 Genomes gVCF mapped to hs37d5 for HG03558. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907660.v1
title: gVCF_NA18998

description: 1000 Genomes gVCF mapped to hs37d5 for NA18998. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907609
title: gVCF_HG03557

description: 1000 Genomes gVCF mapped to hs37d5 for HG03557. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907624
title: gVCF_NA18997

description: 1000 Genomes gVCF mapped to hs37d5 for NA18997. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907642
title: gVCF_HG01874

description: 1000 Genomes gVCF mapped to hs37d5 for HG01874. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907609.v1
title: gVCF_HG03557

description: 1000 Genomes gVCF mapped to hs37d5 for HG03557. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907624.v1
title: gVCF_NA18997

description: 1000 Genomes gVCF mapped to hs37d5 for NA18997. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907480
title: gVCF_NA18995

description: 1000 Genomes gVCF mapped to hs37d5 for NA18995. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907567
title: gVCF_HG01873

description: 1000 Genomes gVCF mapped to hs37d5 for HG01873. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907642.v1
title: gVCF_HG01874

description: 1000 Genomes gVCF mapped to hs37d5 for HG01874. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907651.v1
title: gVCF_HG03558

description: 1000 Genomes gVCF mapped to hs37d5 for HG03558. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907474
title: gVCF_HG03556

description: 1000 Genomes gVCF mapped to hs37d5 for HG03556. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907567.v1
title: gVCF_HG01873

description: 1000 Genomes gVCF mapped to hs37d5 for HG01873. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907465
title: gVCF_NA18994

description: 1000 Genomes gVCF mapped to hs37d5 for NA18994. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907474.v1
title: gVCF_HG03556

description: 1000 Genomes gVCF mapped to hs37d5 for HG03556. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307
DOI: 10.6084/m9.figshare.7907480.v1
title: gVCF_NA18995

description: 1000 Genomes gVCF mapped to hs37d5 for NA18995. Complete collection: https://doi.org/10.6084/m9.figshare.c.4414307